- Home
- CDNA vs SNCY Comparison
CDNA vs SNCY Comparison
Compare CDNA & SNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- SNCY
- Stock Information
- Founded
- CDNA 1998
- SNCY 1982
- Country
- CDNA United States
- SNCY United States
- Employees
- CDNA N/A
- SNCY N/A
- Industry
- CDNA Medical Specialities
- SNCY Air Freight/Delivery Services
- Sector
- CDNA Health Care
- SNCY Consumer Discretionary
- Exchange
- CDNA Nasdaq
- SNCY Nasdaq
- Market Cap
- CDNA 1.1B
- SNCY 950.5M
- IPO Year
- CDNA 2014
- SNCY 2021
- Fundamental
- Price
- CDNA $18.92
- SNCY $12.82
- Analyst Decision
- CDNA Buy
- SNCY Buy
- Analyst Count
- CDNA 8
- SNCY 7
- Target Price
- CDNA $29.43
- SNCY $19.29
- AVG Volume (30 Days)
- CDNA 912.4K
- SNCY 832.4K
- Earning Date
- CDNA 05-08-2025
- SNCY 05-05-2025
- Dividend Yield
- CDNA N/A
- SNCY N/A
- EPS Growth
- CDNA N/A
- SNCY N/A
- EPS
- CDNA 0.93
- SNCY 0.96
- Revenue
- CDNA $333,785,000.00
- SNCY $1,075,739,000.00
- Revenue This Year
- CDNA $13.32
- SNCY $10.53
- Revenue Next Year
- CDNA $14.99
- SNCY $10.09
- P/E Ratio
- CDNA $20.44
- SNCY $13.55
- Revenue Growth
- CDNA 19.07
- SNCY 2.49
- 52 Week Low
- CDNA $7.42
- SNCY $9.22
- 52 Week High
- CDNA $34.84
- SNCY $18.59
- Technical
- Relative Strength Index (RSI)
- CDNA 36.93
- SNCY 24.61
- Support Level
- CDNA $17.73
- SNCY $12.95
- Resistance Level
- CDNA $22.61
- SNCY $15.82
- Average True Range (ATR)
- CDNA 1.31
- SNCY 0.88
- MACD
- CDNA -0.35
- SNCY -0.43
- Stochastic Oscillator
- CDNA 18.97
- SNCY 1.62
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About SNCY Sun Country Airlines Holdings Inc.
Sun Country Airlines Holdings Inc operates low-cost air carriers. The business has two operating segments: Passenger and Cargo. The passenger segment has two internal passenger groups Scheduled service and Charter. The Cargo segment provides air cargo services. The majority of the revenue is from the passenger segment.